Merck shares fall as 2026 guidance disappoints despite solid Q4 results
Go back to Merck shares fall as 2026 guidance disappoints despite solid Q4 results| Merck & Co. (NYSE: MRK) | Delayed: 113.40 -0.47 (0.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $113.87 | 52 Week High | $65.46 | |||
| Open | $113.97 | 52 Week Low | $47.97 | |||
| Day High | $114.36 | P/E | 77.14 | |||
| Day Low | $113.36 | EPS | $1.47 | |||
| Volume | 988,173 | |||||

